Article Details

Aveo sells to LG Chem after turnaround for kidney cancer drug | BioPharma Dive

Retrieved on: 2022-10-18 21:50:33

Tags for this article:

Click the tags to see associated articles and topics

Aveo sells to LG Chem after turnaround for kidney cancer drug | BioPharma Dive. View article details on HISWAI: https://www.biopharmadive.com/news/aveo-oncology-lg-chem-fotivda-tivozanib-deal/634369/

Excerpt

The biotech survived multiple drug rejections, shareholder lawsuits and a federal investigation before winning approval of Fotivda, ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up